Fresenius Medical Care (NYSE:FMS) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Fresenius Medical Care (NYSE:FMS) in a note issued to investors on Thursday. The firm set a “strong-buy” rating on the stock.

Other research analysts have also issued research reports about the company. Berenberg Bank began coverage on Fresenius Medical Care in a report on Wednesday, November 6th. They issued a “buy” rating and a $25.60 target price on the stock. Truist Financial upped their price objective on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a research report on Monday, October 7th.

Fresenius Medical Care Stock Performance

Shares of FMS stock opened at $22.02 on Thursday. The stock’s 50-day moving average price is $20.97 and its 200 day moving average price is $20.33. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $12.92 billion, a PE ratio of 18.20, a price-to-earnings-growth ratio of 1.03 and a beta of 0.91. Fresenius Medical Care has a 52-week low of $17.93 and a 52-week high of $22.76.

Hedge Funds Weigh In On Fresenius Medical Care

Institutional investors and hedge funds have recently made changes to their positions in the stock. Allworth Financial LP grew its stake in Fresenius Medical Care by 53.1% in the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock valued at $36,000 after acquiring an additional 581 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in shares of Fresenius Medical Care during the 3rd quarter worth approximately $38,000. GAMMA Investing LLC lifted its stake in Fresenius Medical Care by 50.4% in the 3rd quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock valued at $106,000 after buying an additional 1,675 shares in the last quarter. ORG Wealth Partners LLC acquired a new stake in Fresenius Medical Care during the 3rd quarter valued at $112,000. Finally, Venturi Wealth Management LLC increased its position in Fresenius Medical Care by 1,045.8% during the third quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock worth $112,000 after buying an additional 4,800 shares in the last quarter. 8.25% of the stock is owned by institutional investors and hedge funds.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.